George Elston | Chief Financial Officer & Head, Corporate Development |
Nancy Lurker | President & Chief Executive Officer |
Jay Duker | Chief Strategic Scientific Officer |
Scott Jones | Chief Commercial Officer |
Jennifer Kim | Cantor Fitzgerald |
Georgi Yordanov | Cowen and Company |
Yatin Suneja | Guggenheim Partners |
Yi Chen | H.C. Wainwright |
Yale Jen | Laidlaw |
Andrew D'Silva | B. Riley Securities |
Good morning. My name is Norma and I'll be your conference operator today. At this time, I would like to welcome everyone to EyePoint Pharmaceuticals' Second Quarter 2021 Financial Results and Recent Corporate Developments Conference Call. There will be a question-and-answer session to follow at the conclusion of the prepared remarks. Please be advised that the call is being recorded at the company's request.